Neonatal Ovine Pulmonary Dendritic Cells Support Bovine Respiratory Syncytial Virus Replication with Enhanced Interleukin (IL)-4 And IL-10 Gene Transcripts by Fach, Sasha J. et al.
Veterinary Pathology Publications and Papers Veterinary Pathology
4-10-2007
Neonatal Ovine Pulmonary Dendritic Cells
Support Bovine Respiratory Syncytial Virus
Replication with Enhanced Interleukin (IL)-4 And
IL-10 Gene Transcripts
Sasha J. Fach
Iowa State University
David K. Meyerholz
Iowa State University
Jack M. Gallup
Iowa State University, eag@iastate.edu
Mark R. Ackermann
Iowa State University, mackerma@iastate.edu
Howard D. Lehmkuhl
United States Department of Agriculture
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/vpath_pubs
Part of the Immunology and Infectious Disease Commons, and the Veterinary Pathology and
Pathobiology Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
vpath_pubs/10. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Veterinary Pathology at Iowa State University Digital Repository. It has been accepted for
inclusion in Veterinary Pathology Publications and Papers by an authorized administrator of Iowa State University Digital Repository. For more
information, please contact digirep@iastate.edu.
Neonatal Ovine Pulmonary Dendritic Cells Support Bovine Respiratory
Syncytial Virus Replication with Enhanced Interleukin (IL)-4 And IL-10
Gene Transcripts
Abstract
The lung microenvironment is constantly exposed to microorganisms and particulate matter. Lung dendritic
cells (DCs) play a crucial role in the uptake and processing of antigens found within the respiratory tract.
Respiratory syncytial virus (RSV) is a common respiratory tract pathogen in children that induces an influx of
DCs to the mucosal surfaces of the lung. Using a neonatal lamb model, we examined the in vivo
permissiveness of DCs to RSV infection, as well as overall cell surface changes and cytokine responses of
isolated lung DCs after bovine RSV (BRSV) infection. We report that isolated lung DCs and alveolar
macrophages support BRSV replication. Isolated lung DCs were determined to be susceptible to BRSV
infection as demonstrated by quantification of BRSV non-structural protein 2 mRNA. BRSV infection
induced an initial upregulation of CD14 expression on lung DCs, but by 5 d postinfection expression was
similar to that on control cells. No significant changes in CD80/86 or MHC class I expression were seen on
lung DCs after BRSV infection. Low to moderate expression of MHC class II and DEC-205 was detected by
day 5 postinfection. Initially, on day 3 postinfection, lung DCs from BRSV-infected lambs had decreased
endocytosis of fluorescein isothiocyanate (FITC)–ovalbumin (OVA). The amount of FITC–OVA
endocytosed by lung DCs isolated on day 5 postinfection was similar to that of controls. The most interesting
observation was the induction of immunomodulatory interleukin (IL)-4 and IL-10 cytokine gene
transcription in lung DCs and alveolar macrophages after in vivo infection with BRSV. Overall, these findings
are the first to demonstrate that neonatal lung DCs support in vivo BRSV replication and produce type II
cytokines after viral infection.
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Neonatal Ovine Pulmonary Dendritic Cells Support Bovine
Respiratory Syncytial Virus Replication with Enhanced
Interleukin (IL)-4 and IL-10 Gene Transcripts
SASHA J. FACH,1,2 DAVID K. MEYERHOLZ,3 JACK M. GALLUP,3
MARK R. ACKERMANN,3 HOWARD D. LEHMKUHL,2 and RANDY E. SACCO1,2
ABSTRACT
The lung microenvironment is constantly exposed to microorganisms and particulate matter. Lung
dendritic cells (DCs) play a crucial role in the uptake and processing of antigens found within the
respiratory tract. Respiratory syncytial virus (RSV) is a common respiratory tract pathogen in chil-
dren that induces an influx of DCs to the mucosal surfaces of the lung. Using a neonatal lamb model,
we examined the in vivo permissiveness of DCs to RSV infection, as well as overall cell surface
changes and cytokine responses of isolated lung DCs after bovine RSV (BRSV) infection. We report
that isolated lung DCs and alveolar macrophages support BRSV replication. Isolated lung DCs were
determined to be susceptible to BRSV infection as demonstrated by quantification of BRSV non-
structural protein 2 mRNA. BRSV infection induced an initial upregulation of CD14 expression on
lung DCs, but by 5 d postinfection expression was similar to that on control cells. No significant
changes in CD80/86 or MHC class I expression were seen on lung DCs after BRSV infection. Low
to moderate expression of MHC class II and DEC-205 was detected by day 5 postinfection. Initially,
on day 3 postinfection, lung DCs from BRSV-infected lambs had decreased endocytosis of fluores-
cein isothiocyanate (FITC)–ovalbumin (OVA). The amount of FITC–OVA endocytosed by lung DCs
isolated on day 5 postinfection was similar to that of controls. The most interesting observation was
the induction of immunomodulatory interleukin (IL)-4 and IL-10 cytokine gene transcription in lung
DCs and alveolar macrophages after in vivo infection with BRSV. Overall, these findings are the
first to demonstrate that neonatal lung DCs support in vivo BRSV replication and produce type II
cytokines after viral infection.
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INTRODUCTION
RESPIRATORY SYNCYTIAL VIRUS (RSV) is a prominentviral pathogen whose tropism for the lower respira-
tory tract causes severe bronchiolitis and pneumonia. In-
fants and young children are most susceptible to the virus
and reinfections are common because of an ineffective
immune response to the virus (17,18,43). The pathogen-
esis of RSV is believed to be a combination of host proin-
flammatory cytokine production and the cytopathic ef-
fects of viral replication (40). Lung epithelial cells are a
primary site for RSV replication, but data from studies
with monocyte-derived dendritic cells (MDDCs) and
alveolar macrophages (AMs) indicate that in vitro repli-
cation of the virus does occur in other cell types
(6,14,21,32).
An influx of DCs after RSV infection has been docu-
mented within the lungs of infected mice and by isola-
tion of DCs from nasal washes of RSV-infected children
(3,13). Dendritic cells are important sentinels of the im-
mune system and play a crucial role in antigen capture,
processing, and presentation to T cells. As the most po-
tent antigen-presenting cells (APCs), DCs link the innate
and adaptive immune responses after microbial infection.
On viral infection, DCs are well equipped to prime T cells
for primary and secondary antiviral responses. Therefore,
viruses have been found to target DCs and modulate sur-
face antigen expression, maturation, and cytokine pro-
duction (33). A prominent respiratory pathogen belong-
ing to the same Paramyxoviridae family as RSV is
measlesvirus (MV), whose immunosuppression of DCs
has been well documented using in vitro-derived DCs
(CD34 precursors or monocytes) or Langerhans cells
(16,35,36). MV modulates infected DCs through inhibi-
tion of maturation, interleukin (IL)-12 production, and
CD80 and CD86 expression. In addition, herpesvirus
(23), poliovirus (42), and vaccinia virus (8) have been
shown to infect DCs and suppress their maturation, anti-
gen presentation, and cytokine production.
To date, only in vivo adult lung DCs or in vitro-derived
DCs have been examined after RSV infection (1,3,14,45).
Neonatal, tissue-isolated lung DCs have not been exam-
ined ex vivo after RSV infection. In the present studies, we
used a neonatal lamb model of experimental bovine RSV
(BRSV) infection as previously described (22,30). Neona-
tal lambs have been used in pulmonary studies of naturally
occurring respiratory diseases (26,27,30). The first aim of
these studies was to isolate neonatal lung DCs after in vivo
BRSV infection to determine whether these cells would
support viral replication. Second, lung DCs were exam-
ined to determine the effects of viral infection on surface
antigen expression and cytokine mRNA induction. We pre-
viously developed a procedure for the isolation and en-
richment of CD11c lung DCs from neonatal lambs (9).
In the present study, we report that BRSV replication oc-
curs within isolated lung DCs and AMs in vivo. Pheno-
typic changes due to the effects of viral infection were ex-
amined. Functional characteristics of lung DCs were
determined by antigen uptake assays and cytokine gene
transcription. Interestingly, BRSV induced IL-4 and IL-10
gene transcription in lung DCs and AMs. Results indicate
that isolated lung APCs can support BRSV replication and
that immunomodulatory cytokines are upregulated early in
infection.
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MATERIALS AND METHODS
Animals and experimental procedure
Healthy 2- to 4-d-old lambs of mixed Rambouillet and
Polypay breeds were used for the experiments. Lambs re-
ceived ceftiofur sodium (Naxcel, 2.2 mg/kg once per day,
intramuscular) to prevent secondary bacterial complica-
tions (41) as previously done in a premature lamb model
(30). Lambs were bottle fed four times per day with com-
mercial milk replacer. Lambs received an intratracheal
inoculation of either 22 mL of BRSV 375 inoculum or
sterile medium with a 30-cm3 sterile syringe and 20-
gauge needle. Necropsies of day 3 postinoculation lambs
(n  6), day 5 postinoculation lambs (n  6), or control
lambs (n  6) were conducted in two separate experi-
ments according to the following procedure. Lambs were
killed with an intravenous injection of sodium pentobar-
bital. During necropsy, the abdominal cavity was opened
and the abdominal aorta was severed. Lungs were per-
fused by a similar procedure to that previously described
(9,38). Briefly, the pulmonary artery was clamped as it ex-
its the heart and catheterized with an 18-gauge needle dis-
tal to the clamp. The vasculature of the lungs was perfused
with sterile phosphate-buffered saline (PBS) until the lungs
were cleared of peripheral blood and were pale pink in
color. The lungs were aseptically removed, lavaged with
sterile PBS to remove alveolar macrophages, and placed
in sterile PBS containing 1% antibiotic–antimycotic (In-
vitrogen, Carlsbad, CA). Accepted principles of animal
care were followed and experiments were approved by the
National Animal Disease Center (NADC, Ames, IA) An-
imal Care and Use Committee.
Viral inoculum
Bovine RSV (BRSV) 375 was propagated on adherent
bovine turbinate cells and the viral inoculum was pre-
pared as previously described (22,30). Briefly, by 7 d of
incubation, or when more than 90% of virally induced
cytopathic effect was observed, flasks were frozen at
80°C. Within 2 d, the flasks were thawed and the me-
dia were pooled and centrifuged to remove cellular de-
bris. After thorough mixing and sterile filtration, viral in-
oculum was aliquoted and stored at 80°C. A standard
plaque assay was used to determine the tissue culture in-
fectious dose (TCID50), 104.9 TCID50/mL (3.97  104
plaque-forming units [PFU]/mL). The viral inoculum was
BVDV free as tested by polymerase chain reaction (PCR)
(data not shown).
Pulmonary DC isolation and enrichment
Neonatal lamb pulmonary DCs were isolated as pre-
viously described (9). Briefly, the entire lung was cut into
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small pieces with sterile scissors and forceps and then di-
gested in RPMI 1640 (Invitrogen) containing Liberase
Blendzyme 3 (7 mg/mL; Roche Applied Science, Indi-
anapolis, IN) and DNase I, type IV from bovine pancreas
(50 g/mL; Sigma, St. Louis, MO) for 1 h at 37°C. The
enzymatic digestion was stopped by the addition of 10%
fetal bovine serum (FBS) to the decanted supernatant and
the entire digestion step was repeated on the remaining
tissue pieces. The cell suspension was filtered through
sterile cheesecloth and washed with PBS. Contaminating
red blood cells (RBCs) were removed from cell prepara-
tions by hypotonic lysis. Cells were resuspended in sup-
plemented RPMI 1640 (cRPMI) containing 10% FBS
(Atlanta Biologicals, Lawrenceville, GA), 10% lamb
serum, 2 mM L-glutamine, and 1% antibiotic–antimycotic
(all from Invitrogen GIBCO, Grand Island, NY) and in-
cubated for 12 h at 37°C in an atmosphere of 5% CO2.
Adherent and nonadherent cells were collected, washed,
and incubated for 10 min at room temperature with 10%
normal goat serum (Invitrogen) to block nonspecific
binding. Cells were washed and stained with monoclonal
antibody BAQ153A (anti-ovine CD11c; VMRD, Pull-
man, WA) followed by incubation with magnetic Mi-
croBeads (Miltenyi Biotec, Auburn, CA). CD11c DCs
(lung DCs) were obtained by twice positively sorting with
a magnetically activated cell sorter (Miltenyi Biotec).
Immunohistochemistry
Samples of PBS-perfused lung were frozen in Tissue-
Tek O.C.T. compound (Sakura Finetek USA, Torrance,
CA) in an ethanol–dry ice bath. Sections were cut onto
silanated glass slides, fixed in acetone for 5 min, and
stored at 80°C. Slides were rehydrated in 1 Tris
buffer and blocked with normal goat serum (Kirkegaard
& Perry Laboratories, Gaithersburg, MD) for 30 min at
room temperature. The slides were washed in 1 Tris
buffer and incubated with primary antibody BAQ153A
(anti-ovine CD11c; VMRD) diluted in 1 Tris buffer,
PBS, and 3% bovine serum albumin (BSA) overnight at
4°C. Slides were rinsed and polyclonal BRSV–fluores-
cein isothiocyanate (FITC) (50 L; VMRD) was added
for 30 min at 37°C. Slides were washed with 1 Tris
buffer and incubated for 30 min at 37°C with isotype-
specific secondary antibodies conjugated to Alexa Fluor
633 (Invitrogen Molecular Probes, Eugene, OR). To vi-
sualize nuclei, slides were washed and incubated with
4,6-diamidino-2-phenylindole, dilactate (DAPI, 300
nM; Invitrogen Molecular Probes) for 5 min at room tem-
perature. The slides were washed with 1 Tris buffer and
coverslips were mounted with a 50:50 glycerin–PBS so-
lution. Tissue sections were examined with a Leica TCS-
NT confocal scanning laser microscope (Leica Mi-
crosystems, Exton, PA). Images were prepared with
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Adobe Photoshop version CS (Adobe, San Jose, CA) and
InDesign version 3 (Adobe).
Flow cytometry
Isolated CD11c cells were analyzed for cell surface
antigens by three-color flow cytometry. Cell concentra-
tions were adjusted to 1 105 cells/mL and stained with
different combinations of primary and secondary anti-
bodies diluted in FACS buffer (balanced salt solution
with 1% FBS and 0.1% sodium azide). Ovine-specific
monoclonal antibodies obtained from VMRD were used
for detection of CD14 (CAM36A), CD11c (BAQ153A),
MHC class I (BC5), and MHC class II (TH14B). Cross-
reactive CD11b (CC126) and DEC-205 (CC98) mono-
clonal antibodies were obtained from Serotec (Raleigh,
NC). CD80/86 was detected with human CD152-muIg/R-
phycoerythrin (PE) fusion protein (Ancell, Bayport,
MN). Isotype-specific primary antibodies used were anti-
mouse IgG1, IgG2b, IgG2a, and IgM (Serotec). Sec-
ondary antibodies (SouthernBiotech, Birmingham, AL)
included anti-IgM–PE, anti-IgG2b–PE, anti-IgG2b–
FITC, anti-IgG2a–FITC, and anti-IgM–FITC. Anti-IgG1
Tricolor was obtained from Invitrogen Caltag Laborato-
ries (Burlingame, CA). Cells were washed with FACS
buffer and resuspended in 2% paraformaldehyde in PBS.
For each sample 10,000 events were collected with a BD
Biosciences Immunocytometry Systems LSR flow cy-
tometer (San Jose, CA). Analysis of cell surface marker
expression was done with FloJo software (Tree Star, Ash-
land, OR).
Tracer endocytosis
FITC-conjugated ovalbumin (FITC–OVA; Invitrogen
Molecular Probes) and FITC-conjugated dextran (FITC–
dextran; Invitrogen Molecular Probes) were used to ex-
amine the endocytic abilities of the lung DC populations.
CD11c cell concentrations were adjusted to 1 105 cells/
mL and incubated at 37 or 4°C for 1 h with FITC–OVA
or FITC–dextran (1 mg/mL). Cells were washed with
FACS buffer and resuspended in 2% paraformaldehyde
in PBS. For each sample 10,000 events were acquired
with a flow cytometer (Becton Dickinson LSR). Data
were analyzed with FloJo software (Tree Star).
RNA extraction and cDNA synthesis
Sorted CD11c pulmonary cells were pelleted in ster-
ile 1.5-mL Eppendorf tubes. Cells were resuspended in 600
L of RLT buffer plus 2-mercaptoethanol from the
RNeasy Mini RNA isolation kit (Qiagen, Valencia, CA)
and stored at 80°C. Total RNA was isolated using the
RNeasy Mini RNA isolation kit (Qiagen) according to the
manufacturer’s instructions. Contaminating genomic DNA
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was removed during RNA isolation with an on-column
RNase-free DNase I digestion set (Qiagen) according to
the manufacturer’s instructions. Total RNA was eluted by
the addition of 40 L of DNase–RNase-free water. One
microgram of total RNA from each sample was reverse
transcribed with oligo(dT)12–18 primers (Invitrogen).
Cytokine and BRSV nonstructural protein 2
mRNA quantification
Primers were designed specifically for SYBR green
quantification, using the PrimerSelect program (DNAS-
TAR, Madison, WI) with suggested parameters for
SYBR green chemistry that included a product size no
greater than 100–150 base pairs and a 50°C annealing
temperature. Ovine ribosomal protein S15 was chosen as
the endogenous control for the genes of interest, which
are listed in Table 1. Oligo(dT) cDNA was diluted 1:10
in DNase–RNase-free water and 2 L was used for quan-
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tification. SYBR green PCR master mix (Applied Biosys-
tems, Foster City, CA) was used according to the manu-
facturer’s instructions. An Applied Biosystems 7300
Real-Time PCR System machine was used with the same
amplification conditions for all genes of interest: 10 min
at 95°C, 15 sec at 95°C, 40 cycles of 1 min at 50°C, with
a dissociation step of 15 s at 95°C, 30 s at 50°C, 15 s at
95°C. Final relative quantification was calculated by the
2CT method (28), where the amount of target gene is
normalized to an endogenous control (ovine ribosomal
protein S15) and expressed relative to control cells.
Primers were validated on the Applied Biosystems 7300
machine by using serial dilutions of total RNA with ovine
ribosomal protein S15 and target gene primers, whose
values were plotted as the log input amount versus CT
values (target gene CT—endogenous control CT) for rel-
ative efficiency. Only primers with a slope of less than
0.1 were used, because of similar amplification efficien-
cies as the endogenous control.
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TABLE 1. PRIMER SEQUENCES FOR OVINE TARGET AND ENDOGENOUS CONTROL GENES
Primer Sequence (5 → 3) Length (bp) Accession no.
IL-1 Forward ATGGGTGTTCTGCATGAG 63 X54796
IL-1 Reverse AAGGCCACAGGAATCTTG
IL-4 Forward GGACTTGACAGGAATCTC 80 Z11897
IL-4 Reverse CTCAGCGTCTTGTACTC
IL-6 Forward GAGTTGCAGAGCAGTATC 85 X62501
IL-6 Reverse GGCTGGAGTGGTTATTAG
IL-8 Forward AAGCTGGCTGTTGCTCTC 94 X78306
IL-8 Reverse GGCATCGAAGTTCTGTACTC
IL-10 Forward GATGCCACAGGCTGAGAACC 53 U11421
IL-10 Reverse GCGAGTTCACGTGCTCCTTG
IL-12p40 Forward AAGTCACATGCCACAAGG 72 AF004024
IL-12p40 Reverse CACTCCAGAATGAGCTGAG
TNF Forward CTCATCTACTCGCAGGTCCTC 86 X56756
TNF Reverse ACTGCAATGCGGCTGATGG
ovRPS15 Forward TACAACGGCAAGACCTTCAACCAG 105 a
ovRPS15 Reverse GGGCCGGCCATGCTTACG
BRSV
NS2 Forward ACCACTGCTCAGAGATTG 155 NC_001989
NS2 Reverse AATGTGGCCTGTCGTTCATCG
aOvine ribosomal protein S15 mRNA sequence provided by Dr. Sean Limesand, Dept. of Pediatrics, University of Colorado
Health Sciences Center, Perinatal Research Center, Aurora, CO.
In sterile Eppendorf tubes, 20 L of total RNA from
BRSV 375 inoculum and BRSV oligo(dT) cDNA were
treated with RNase If (1 unit/L; New England BioLabs,
Ipswich, MA) or untreated and all four samples were in-
cubated for 30 min at 37°C. The digestion of single-
stranded RNA was stopped by heating the tubes at 70°C
for 20 min. Removal of the RNase enzyme was performed
by Microcon column exclusion (100U columns; Millipore,
Billerica, MA) according to the manufacturer’s instructions.
Samples were quantified with BRSV nonstructural protein
2 (NS2) primers and SYBR green chemistry as previously
described above. No amplification of genomic BRSV NS2
was observed (data not shown).
Statistical analysis
Flow cytometric data were expressed as mean fluo-
rescence intensity  SEM. Cytokine data were expressed
as the fold change in expression relative to controls. Sta-
tistical analysis of the data was performed by unpaired
two-tailed Student t test or analysis of variance
(ANOVA) (cytokine real-time PCR) using GraphPad
Prism software (GraphPad Software, San Diego, CA).
Multiple means comparisons of cytokine data were per-
formed by Bonferroni’s test (Prism software). Signifi-
cance was determined as p 	 0.05.
RESULTS
Colocalization of BRSV and CD11c DCs 
within lung parenchyma
Immunofluorescence staining was used to demonstrate
the presence of BRSV antigen within lung CD11c cells.
Frozen lung sections from the upper right lobe of neonatal
lamb lungs of control, day 3 postinoculation, and day 5
postinoculation lambs were stained for the presence of
BRSV and CD11c. DAPI was used as a nuclear stain to
enhance visualization of the overall cellular distribution
within the tissue sections. Coexpression of BRSV antigen
and CD11c was seen in the alveolar septa and subjacent to
the bronchiolar epithelium (Fig. 1). No BRSV antigen stain-
ing was detected in control lamb lung cryosections (data
not shown). Overall, analysis of the immunofluorescently
stained frozen sections showed BRSV antigens colocalized
within lung CD11c cells. However, additional experi-
ments were required to determine whether lung DCs or
AMs support active viral replication.
BRSV replication within antigen-presenting cells
On initiation of replication, the RNA-dependent RNA
polymerase transcribes the RSV negative-sense genome
NEONATAL DC SUPPORT FOR IN VIVO BRSV REPLICATION
in the 3-to-5 direction. Large amounts of the mRNAs
encoding nonstructural proteins NS1 and NS2 are pro-
duced during viral replication, a result of the genome’s
transcriptional polarity, in which the genes on the 3 end
are transcribed in greater amounts than the 5-end genes
(4,10). To detect BRSV replication within isolated lung
DCs and AMs, primers were designed to the NS2 mRNA
of BRSV and relative quantification was performed by
SYBR green chemistry. Expression of BRSV mRNA was
detected in both DCs and AMs, and the NS2 transcript
levels in AMs exceeded the detected levels in the lung
DCs (Fig. 2). Taken together, these results demonstrate
that both lung DCs and AMs support BRSV replication
in vivo.
Analysis of surface antigen expression
Isolated lung DCs were analyzed for surface antigen
expression 3 and 5 d after inoculation of BRSV. More
than 89% of all isolated CD11c lung DCs coexpressed
DEC-205 (Fig. 3A). A significant increase in CD14 ex-
pression was observed on lung DCs isolated from 3 d
postinoculation lambs when compared with control lung
DCs (Fig. 3B). However, CD14 expression on isolated
lung DCs 5 d postinoculation was similar to that on con-
trol lung DCs. Expression of DEC-205, MHC class I, and
CD80/86 increased from day 3 to day 5 postinoculation,
but no significant differences relative to controls were
noted (Fig. 3B). No significant changes in MHC class II
expression during BRSV infection were observed. Over-
all, BRSV infection induced a notable change in CD14
expression, but no significant changes in expression of
surface antigens necessary for presentation and stimula-
tion of antiviral T cells responses were observed.
Antigen uptake after BRSV exposure
Functional characteristics of lung DCs isolated from
BRSV-infected lambs were assayed by measuring their
endocytic uptake of antigens. Several pathways exist for
antigen uptake and FITC–OVA was used as a measure
of receptor-mediated endocytosis via clathrin-coated pits.
In addition, FITC–dextran uptake was used to measure
mannose receptor-mediated endocytosis by lung DCs.
Endocytosis of FITC–OVA by lung DCs isolated 3 d af-
ter inoculation of BRSV was significantly decreased
compared with controls (Fig. 4). By day 5 postinocula-
tion, lung DCs endocytosed significantly more
FITC–OVA than on day 3 postinoculation (p 	 0.05).
Mannose receptor-mediated endocytosis of FITC–dex-
tran was lower in the controls and in lung DCs from
BRSV-infected lambs, and no significant differences
were noted (Fig. 4). Therefore, lung DCs were still able
to take up antigen after 5 d of BRSV infection.
123
Production of immunomodulatory IL-4 and 
IL-10 by lung DCs after BRSV infection
Cytokine gene expression was quantified on the basis
of SYBR green chemistry, using primers specific for
proinflammatory and immunomodulatory genes. A less
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than 2-fold increase in proinflammatory mediators IL-1,
tumor necrosis factor (TNF)-, IL-6, IL-8, and IL-12p40
was detected in isolated lung DCs from day 3 and 5
postinoculation lambs (Fig. 5). In addition, similar results
were seen in AMs, although expression of IL-6 and IL-
12p40 mRNAs was higher than in lung DCs. Of note, a
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FIG. 1. BRSV antigen colocalizes with CD11c cells in the lungs of neonatal lambs. Neonatal ovine lung cryosections were
immunofluorescently stained with a primary antibody directed against CD11c (C, F, and I) followed by a secondary antibody
fluorescently labeled with Alexa Fluor 633 (red). Directly conjugated BRSV–FITC (B, E, and H) antibody (green) was used to
identify cells containing BRSV. Coexpression of CD11c and the virus is shown by yellow. Multicolor immunofluorescence stain-
ing shows dual-labeled DCs (A, D, and G) and nuclear staining with DAPI (blue). The enlarged view (D–F) is of the inset in
(A) and an additional and different enlarged view (G–I) reveals more CD11c and BRSV colocalization. Data are representative
of two experiments with 12 infected lambs. Scale bars: (A–C) 20 m; (D–I) 10 m.
striking induction of IL-4 mRNA transcripts was detected
in lung DCs at both 3 and 5 d postinoculation. Moreover,
a 10- to 15-fold increase in AM IL-4 mRNA transcrip-
tion was observed, but this was lower than the levels in
the lung DCs. Finally, we observed a 2- to 4-fold increase
in IL-10 mRNA transcripts in lung DCs. Of note, no sig-
nificant increases in cytokine or chemokine mRNA ex-
pression were observed in samples recovered from DCs
or AMs on day 3 compared with day 5 postinoculation.
Taken together, these results show that there is an early
bias toward the production of immunomodulatory IL-4
and IL-10 gene transcripts in lung DCs and AMs isolated
from BRSV-infected lambs.
DISCUSSION
In the present studies, we used a previously described
neonatal lamb model of RSV infection (22,24,25,29–31) in
which the pathogenesis and lesions observed (bronchioli-
tis, inflammatory cell infiltrates, and goblet cell hyperpla-
sia) are similar to RSV infection in children. Interestingly,
alveolar development begins prenatally in both humans and
lambs, whereas mice have postnatal alveolar development
(11). Therefore, neonatal lamb lungs are similar develop-
mentally to neonatal humans and represent a comparable
model for RSV infection. When comparing species-specific
RSV strains, BRSV and ovine RSV are phylogenetically
the most closely related sequences to the human RSVs.
These ruminant RSV strains are not completely different
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viruses but rather represent separate antigenic subgroups of
the human RSV strains (7,10). The conservation pattern of
amino acids in the human RSV subgroups is similar to that
seen in BRSV, but some differences are observed (10).
Overall, molecular cloning and field studies have demon-
strated that human and bovine RSV are closely related,
share common antigenic epitopes, and induce similar patho-
genesis (2,34,46). Lambs can be naturally infected with
BRSV and are fully susceptible to experimental BRSV in-
fections (2). Taken together, lambs are an excellent model
for experimental RSV infection.
At present, there are no data available examining in
vivo-derived lung DCs after RSV infection in a neonatal
animal model (3). The results derived from neonatal
lambs in the present study demonstrate that BRSV anti-
gen and CD11c colocalize on cells within the lung
parenchyma and alveolar spaces. Three and 5 d postinoc-
ulation with BRSV, isolated CD11c lung DCs and AMs
contained NS2 mRNA transcripts, indicative of BRSV
replication within these cells. After in vivo BRSV infec-
tion, on day 3 postinoculation, lung DCs increased CD14
expression and exhibited decreased endocytosis of
OVA–FITC. By day 5 postinoculation, lung DCs ex-
pressed low to moderate levels of DEC-205, CD14, and
MHC class II, whereas higher expression of MHC class
I and CD80/86 were detected. Inflammatory mediators
IL-1, IL-6, IL-8, IL-12p40, and TNF- were transcribed
in small amounts within lung DCs, whereas a 3.5- and
75-fold increase in gene transcripts of IL-10 and IL-4
were quantitated within these cells. Higher levels of 
IL-6 and IL-12p40 were transcribed in isolated AMs
compared with lung DCs. Overall, BRSV leads to a type
II skewing of the lung DC response by inducing IL-4 and
IL-10 mRNAs. The virus may inhibit the initial matura-
tion of the lung DCs, because CD80/86 and MHC class
I expression is not increased until day 5 after infection.
Overall, RSV may modulate lung DCs by inducing an
immunomodulatory cytokine response.
Identification and magnetic sorting of DCs were per-
formed with the CD11c monoclonal antibody (mAb)
BAQ153A, which specifically labels a majority of affer-
ent lymph DCs and few lung tissue macrophages in the
ovine species (15). Our results demonstrate the colocal-
ization of BRSV antigen and CD11c cells within frozen
lung tissue sections from BRSV-infected lambs. These
results are consistent with other in vivo data based on the
use of isolated cells from nasal washes of infected chil-
dren and indicating that HLA-DR-positive cells coex-
press RSV fusion (F) protein (13). In addition to stain-
ing for viral antigen, we used detection of viral mRNA
to address whether BRSV was capable of replicating
within lung DCs in vivo. Three and 5 d postinoculation
of BRSV, our results indicate that both lung DCs and
AMs are permissive to BRSV infection and support repli-
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FIG. 2. BRSV replicates within lung dendritic cells (DCs)
and alveolar macrophages (AMs). Isolated lung DCs and AMs
were lysed in RLT buffer and total RNA was isolated.
Oligo(dT) cDNA and BRSV NS2-specific primers with SYBR
green chemistry were used for quantification of viral replica-
tion. Lung DCs supported BRSV replication, but less so than
AMs. Data are representative of two experiments with six lambs
per treatment group. Pi, Postinoculation.
FIG. 3. BRSV infection of neonatal ovine lungs induces modulation of surface antigen expression on CD11c lung DCs.
Lung DCs were sorted magnetically to purify CD11c cells from digested neonatal lung suspensions from controls, day 3 postinoc-
ulation lambs, and day 5 postinoculation lambs. Flow cytometric analysis of surface antigen expression revealed that 89% of the
sorted lung DCs coexpressed CD11c and DEC-205 (A). Statistical analysis indicated a higher mean fluorescence intensity (MFI)
expression of CD14 on lung DCs isolated on day 3 postinoculation when compared with controls or day 5 postinoculation lung
DCs (B) (*p 	 0.05). MHC class I and CD80/86 expression was higher on isolated lung DCs from day 5 postinoculation lambs.
Each column represents the average of the MFI staining for the indicated cell surface antigen minus the MFI staining of the ap-
propriate isotype control. Data are representative of two experiments with six lambs per experimental group.
cation, as shown by an increase in NS2 mRNA tran-
scripts. These results are in agreement with in vitro data
demonstrating that monocyte-derived DCs (MDDCs) can
be productively infected with RSV (14). In addition, in
vitro data derived from monocyte- or cord blood-derived
DCs indicate that these cells are permissive to RSV in-
fection (1,21). Taken together, these results demonstrate
that isolated lung DCs and AMs are permissive to RSV
infection and support viral replication in vivo.
Previously, we have reported that neonatal MDDCs
and lung tissue-derived DCs differ phenotypically. Lung
DCs express higher levels of CD80/86, MHC class I, and
MHC class II compared with mature MDDCs (9). In ad-
dition, levels of CD14 expressed on lung DCs are lower
than levels expressed on macrophages (9). After in vivo
BRSV infection, we report here a significant increase in
CD14 expression on day 3 postinoculation. This obser-
vation is reminiscent of data demonstrating an increase
in Toll-like receptor (TLR)4 expression on monocytes
isolated from RSV-infected children during the acute
phase of infection (12). Together, these data are sup-
ported by the known trimeric clustering of CD14, MD2,
and TLR4 on the surface of cells (39). In contrast, it was
noted that CD14 expression on lung DCs isolated 5 d
postinoculation was similar to levels observed on control
lung DCs. Given the dynamic nature of DCs, it is not
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clear at present whether DCs present in the lung on day
3 are the same population present on day 5. Expression
of DEC-205, MHC class I, and CD80/86 was not signif-
icantly increased relative to controls, although a trend for
increased expression of these molecules by day 5
postinoculation can be observed. MHC class II was ex-
pressed at low levels on lung DCs from BRSV-infected
lambs and control lambs. There was no observed pheno-
typic modulation of bovine MDDCs exposed to BRSV
(Snook strain) as evidenced by the lack of altered MHC
class I, MHC class II, and CD80/86 expression (44).
However, infection of human monocyte- or cord blood-
derived DCs with human RSV resulted in increased ex-
pression of MHC class I and II, CD80, and CD86 (14,21).
Further studies are warranted to investigate modulation
of DC surface antigens after RSV infection.
Mature DCs are potent inducers of an adaptive immune
response to microbial infection in the lung microenvi-
ronment. As a functional measure of maturation state,
isolated lung DCs from control and BRSV-infected lambs
were incubated with FITC–OVA and FITC–dextran. Im-
mature DCs are known to actively take up antigen via
macropinocytosis and receptor-mediated endocytosis
(20). The findings indicate that isolated lung DCs from
day 3 postinfection lambs phagocytosed significantly less
FITC–OVA than did controls, with no difference on day
5. A potential explanation for these data is an initial in-
hibition of DC antigen uptake early in RSV infection, but
recovery of DC tracer endocytosis by day 5. On the other
hand, it is plausible that mature day 3 DCs have migrated
to the draining lymph node and there are more immature
DCs present in the lung on day 5. The observation of re-
duced tracer uptake is supported by work in mice infected
with RSV, where isolated lung DCs were reported to have
low FITC–dextran uptake after 10 d of viral infection (3).
In contrast to FITC–OVA, uptake of FITC–dextran via
mannose receptor-mediated endocytosis was lower and
not significantly altered.
RSV infection is a known inducer of inflammatory and
immunomodulatory mediators in APCs in vitro (1,14,44).
In the present study, we quantitated mRNA levels pre-
sent in isolated lung DCs and AMs after BRSV infec-
tion. Alveolar macrophages produced more IL-6 mRNA
transcripts compared with lung DCs. In addition, the in-
duction of IL-12p40 mRNA within AMs was greater than
levels detected within lung DCs. In general, BRSV in-
fection induced a 1.5- to 2-fold increase in the expres-
sion of IL-1, IL-6, IL-8, IL-12p40, and TNF- mRNA
transcripts within lung DCs. Previous studies using hu-
man monocyte- or cord blood-derived DCs report simi-
lar cytokines and chemokines being produced after RSV
infection (1,14). Our results are similar to the cytokine
mRNA profile observed in vitro by BRSV infection of
bovine MDDCs (44). Interestingly, we observed in-
creases in both IL-4 and IL-10 gene transcription within
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FIG. 4. Uptake of FITC–ovalbumin (FITC–OVA) and
FITC–dextran by isolated lung DCs. Magnetically sorted
CD11c lung DC cell numbers were adjusted to 1  105
cells/mL and incubated with either FITC–OVA or FITC–dex-
tran for 1 h at 37 or 4°C. Data are expressed as the change in
mean fluorescence intensity (MFI) values, that is, the 37°C MFI
values minus the 4°C MFI values. Statistical analyses indicate
that lung DCs on day 3 postinoculation endocytosed less
FITC–OVA than either the controls or day 5 postinoculation
lung DCs (*p 	 0.05). Data are representative of two experi-
ments with six lambs per treatment group.
lung DCs after BRSV infection. Increased levels of I
L-4 protein in nasal washes from RSV-infected children
have been reported although the exact cell source was not
determined (13). Human plasmacytoid DCs isolated from
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peripheral blood mononuclear cells were infected with
RSV and were reported to produce IL-4 after a 24-h ex-
posure to the virus (14). Thus, it is plausible that DCs are
a source of IL-4 during RSV infection in neonates.
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FIG. 5. Quantification of cytokine responses in
lung dendritic cells (DCs) and alveolar macrophages
(AMs) isolated after in vivo BRSV infection. Isolated
lung DCs or AMs were resuspended in RLT buffer and
total RNA was isolated. After reverse transcription,
oligo(dT) cDNA and ovine-specific primers with SYBR
green master mix were used to quantify the genes of in-
terest. mRNA gene expression is shown as the fold
change relative to cells from control lambs. Expression
of both IL-10 and IL-4 genes in lung DCs is induced
after BRSV inoculation. AMs produce greater amounts
of IL-6 compared with lung DCs. Data are representa-
tive of two experiments with six lambs per time point.
Accumulating experimental data suggest that severe
RSV infections early in childhood may predispose these
children later on to develop recurrent wheezing, asthma,
or other chronic pulmonary disorders (37). The progres-
sion of RSV disease is associated with a type II cytokine
response and we report here that lung DCs are a likely
source of IL-4 and IL-10 observed after infection. It has
been suggested that the type II cytokine response after RSV
infection predisposes these children to future pulmonary
problems. Studies have associated severe RSV infections
with IL-4 haplotypes and/or polymorphisms (5,19), further
supporting the importance of IL-4 during RSV infections.
Taken together, our results suggest that in vivo RSV in-
fection may induce neonatal lung DCs to produce non-
protective cytokine responses that may result in enhanced
host susceptibility to secondary infections or chronic pul-
monary diseases such as allergies or asthma.
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